Correlation between EGFR gene mutation pattern and Akt phosphorylation in pulmonary adenocarcinomas

12Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The detection of gene mutation of epithelial growth factor receptor (EGFR) is important to predict the therapeutic effect of gefitinib. Recently, it was reported that examination of the activation of the downstream protein of EGFR is useful in the same way as the EGFR mutation. Therefore the purpose of the present paper was to determine whether activation of Akt and Erk, which are downstream proteins, and the EGFR gene mutation pattern was correlated. A total of 130 pulmonary adenocarcinomas were studied for the gene mutations of EGFR in exon 19 and 21, and the phosphorylation of Akt and Erk was investigated by immunostaining. The EGFR mutation was detected in 32%, the positivity of p-Akt was 51%, and the rate of p-Erk was 27%. The EGFR mutation-positive cases were the minority in p-Akt-negative cases, and the p-Akt expression was significantly associated with the mutation of EGFR (P = 0.0014). In addition, there was a significant correlation between the L858R mutation and the expression of p-Akt (P = 0.040). It is suggested that the activation of Akt is dependent on EGFR mutation pattern. © 2007 The Authors.

Cite

CITATION STYLE

APA

Ikeda, S., Takabe, K., Inagaki, M., Funakoshi, N., Suzuki, K., & Shibata, T. (2007). Correlation between EGFR gene mutation pattern and Akt phosphorylation in pulmonary adenocarcinomas. Pathology International, 57(5), 268–275. https://doi.org/10.1111/j.1440-1827.2007.02093.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free